Advertisement

Loading...

Sinopharm Group Co. Ltd.

SHTDY•PNK
Healthcare
Medical - Distribution
$13.00
$0.02(0.12%)
U.S. Market opens in 13h 42m

Sinopharm Group Co. Ltd. (SHTDY) Stock Overview

Explore Sinopharm Group Co. Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.1B
P/E Ratio7.89
EPS (TTM)$1.66
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$12.43
3 Months$13.05
1 Year Target$11.89

SHTDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sinopharm Group Co. Ltd. (SHTDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.89 and a market capitalization of 8.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
1.17%
1-Month Change
-4.13%
3-Month Change
3.01%
6-Month Change
10.26%
Year-to-Date (YTD) Change
3.01%
1-Year Change
11.40%
3-Year Change
-15.03%
5-Year Change
5.52%
All-Time (Max) Change
-39.87%

Contact Information

https://www.sinopharmgroup.com.cn
86 21 2305 2666
Sinopharm Group Building, Shanghai, NaN, 200023

Company Facts

1,082,170 Employees
IPO DateAug 25, 2016
CountryCN
Actively Trading

Frequently Asked Questions